SAN RAFAEL, CA--(Marketwire - December 03, 2012) - Grass Roots Research & Distribution Inc. (GRRD), Wall Street's leading independent micro-cap research firm, has announced that it has initiated coverage on Ingen Technologies Inc. (PINKSHEETS: IGNT) with a STRONG BUY recommendation and a 12-month price target of $.15 per share. GRRD provides an in-depth analysis, including 5-year financial and valuation projections, on Ingen's business and its significant growth drivers. A copy of the report is available at http://ingen-tech.com/files/documents/Ingen_Final_Report_11016012.pdf.
An excerpt from the report states, "IGNT common stock is valued at $0.15 per share, 2727% higher than the current market price of $0.0055 per share. The stock is an interesting short term trade and potentially a good long term investment."
About Grass Roots Research & Distribution Inc. (GRRD)
GRRD is Wall Street's leading independent micro-cap research firm, concentrating on emerging companies with strong management teams focused on shareholder value and sustainable competitive advantage. GRRD, led by renowned security analyst, Paul Cohen, this CFA analyst written research report highlight the company's market opportunity, technology, management, competition and other key differentiators that may affect their long- and short-term valuation. GRRD focuses on those public companies that lack or have minimal Wall Street research analyst coverage. GRRD research reports are commissioned and paid for by the companies covered, or by third parties. For more information, visit: www.grassrootsrd.com.
This report/release is for informational purposes only. All information contained herein is based on public information. GRRD complies with securities laws, regulations and ethical standards as related to our legal and compliance requirements. Certain securities regulations are cited and disclaimed in our Disclaimer. Ethical standards as related to our firm are the foundation of those securities laws and regulations we follow. Our firm is not a member of any association for other research providers. Our firm's policy is to comply with any new securities laws and regulations that might be promulgated in the future. GRRD is a not a registered investment advisor that distributes contracted third party independent research purchased from outside third party contracted securities analysts. To access the complete disclosure and disclaimer, download a copy of the Ingen Technologies Inc. report at www.grassrootsrd.com.
About Ingen Technologies:
Ingen Technologies, Inc. (PINKSHEETS: IGNT), through its wholly owned subsidiary, is an emerging medical device manufacturer that has developed and patented a proprietary medical technology for patients suffering with COPD (Chronic Obstructive Pulmonary Disease) such as chronic bronchitis, emphysema, and asthmatic bronchitis and who require oxygen therapy through home healthcare, hospitals, military and government-based medical facilities. The Company has delivered this product to a global customer base in the $4 billion respiratory market since 1998.
Safe Harbor Statement: The Private Securities Litigation Reform Act of 1995 provides a "Safe harbor" for forward-looking statements. Certain of the statements contained herein, which are not historical facts, are forward-looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company is detailed from time to time in the company's reports filed with the Securities and Exchange Commission.
For more information about Grass Roots Research & Distribution Inc. contact Paul Cohen at email@example.com or visit www.grassrootsrd.com and for more information on Ingen Technologies contact Gary Tilden, COO at firstname.lastname@example.org or go to www.ingen-tech.com.